BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1555305)

  • 1. Clinical restenosis trials: a perspective from the pharmaceutical industry.
    Uprichard AC; Texter M; Canter D
    Circulation; 1992 Apr; 85(4):1636-7. PubMed ID: 1555305
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinapril for coronary artery disease.
    Seth S; Mohan A
    Natl Med J India; 1997; 10(2):73-4. PubMed ID: 9153985
    [No Abstract]   [Full Text] [Related]  

  • 3. Worldwide clinical experience with ACE inhibitors: the role of quinapril. Proceedings of investigators' meeting. Marbella, Spain, June 10-11, 1989.
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S1-63. PubMed ID: 1691401
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
    Mancini GB
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):293-5. PubMed ID: 11800410
    [No Abstract]   [Full Text] [Related]  

  • 5. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
    Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial.
    Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P
    Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of quinapril on intimal hyperplasia after coronary stenting as assessed by intravascular ultrasound.
    Kondo J; Sone T; Tsuboi H; Mukawa H; Kosokabe T; Tsuzuki M; Tomida T; Suzuki T; Kamiya H; Hayashi K; Matsui H; Okumura K
    Am J Cardiol; 2001 Feb; 87(4):443-5, A6. PubMed ID: 11179530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
    Lauten WB; Khan QA; Rajagopalan S; Lerakis S; Rahman ST; Parthasarathy S; Khan BV
    Am J Cardiol; 2003 May; 91(9):1116-9. PubMed ID: 12714159
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): double-blind randomized trial].
    Gnecchi M; Ardissino D
    Ital Heart J Suppl; 2001 Sep; 2(9):1027-8. PubMed ID: 11675825
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of ischemic complications. ACE inhibitor helps in endothelial crisis].
    MMW Fortschr Med; 1999 Oct; 141(43):58-9. PubMed ID: 10912130
    [No Abstract]   [Full Text] [Related]  

  • 13. [Better endothelial function, fewer ischemic problems. An ACE inhibitor provides protection against ischemia].
    MMW Fortschr Med; 2000 Jan; 142(1-2):54-5. PubMed ID: 11291163
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism by which quinapril improves vascular function in coronary artery disease.
    Koh KK; Bui MN; Hathaway L; Csako G; Waclawiw MA; Panza JA; Cannon RO
    Am J Cardiol; 1999 Feb; 83(3):327-31. PubMed ID: 10072217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BANFF: an update.
    Anderson T
    Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
    Pepine C
    Can J Cardiol; 1998 Jul; 14 Suppl D():23D-26D. PubMed ID: 9713427
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertensive patients with signs of coronary heart disease. An ACE inhibitor improves endothelial function].
    MMW Fortschr Med; 2001 Aug; 143(33-34):58-9. PubMed ID: 11561465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endothelium research. ACE inhibitor with high vascular affinity].
    Riem L
    MMW Fortschr Med; 2000 Jun; 142(22):56-7. PubMed ID: 10870387
    [No Abstract]   [Full Text] [Related]  

  • 19. The Quinapril Ischemic Event Trial (QUIET).
    Pitt B
    Blood Press Suppl; 1992; 4():11-2. PubMed ID: 1345328
    [No Abstract]   [Full Text] [Related]  

  • 20. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial.
    Lough M; Cleland J; Langan J; Cowley A; Wade A
    BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.